- Home
- PMEC vs NOTV Comparison
PMEC vs NOTV Comparison
Compare PMEC & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMEC
- NOTV
- Stock Information
- Founded
- PMEC 1984
- NOTV 1974
- Country
- PMEC Singapore
- NOTV United States
- Employees
- PMEC N/A
- NOTV N/A
- Industry
- PMEC
- NOTV Biotechnology: Pharmaceutical Preparations
- Sector
- PMEC
- NOTV Health Care
- Exchange
- PMEC Nasdaq
- NOTV Nasdaq
- Market Cap
- PMEC 56.9M
- NOTV 57.7M
- IPO Year
- PMEC 2023
- NOTV 1997
- Fundamental
- Price
- PMEC $1.87
- NOTV $1.41
- Analyst Decision
- PMEC
- NOTV Strong Buy
- Analyst Count
- PMEC 0
- NOTV 1
- Target Price
- PMEC N/A
- NOTV $5.00
- AVG Volume (30 Days)
- PMEC 244.2K
- NOTV 395.3K
- Earning Date
- PMEC 01-01-0001
- NOTV 08-06-2025
- Dividend Yield
- PMEC N/A
- NOTV N/A
- EPS Growth
- PMEC N/A
- NOTV N/A
- EPS
- PMEC N/A
- NOTV N/A
- Revenue
- PMEC $74,349,000.00
- NOTV $505,299,000.00
- Revenue This Year
- PMEC N/A
- NOTV $5.64
- Revenue Next Year
- PMEC N/A
- NOTV $5.16
- P/E Ratio
- PMEC N/A
- NOTV N/A
- Revenue Growth
- PMEC 2.52
- NOTV 0.85
- 52 Week Low
- PMEC $0.54
- NOTV $1.15
- 52 Week High
- PMEC $1.89
- NOTV $6.48
- Technical
- Relative Strength Index (RSI)
- PMEC 62.47
- NOTV 34.35
- Support Level
- PMEC $1.76
- NOTV $1.36
- Resistance Level
- PMEC $1.88
- NOTV $1.68
- Average True Range (ATR)
- PMEC 0.15
- NOTV 0.11
- MACD
- PMEC 0.02
- NOTV -0.02
- Stochastic Oscillator
- PMEC 96.92
- NOTV 10.00
About PMEC Primech Holdings Ltd.
Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.